Skip to main content

Month: July 2020

Basilea announces data presentations at ESMO Virtual Congress 2020

Basel, Switzerland, July 28, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that three abstracts featuring preclinical and clinical data on its fibroblast growth factor receptor (FGFR) kinase inhibitor derazantinib and its tumor checkpoint controller lisavanbulin are going to be presented as e-posters at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which is taking place from 19-21 September, 2020.Dr. Marc Engelhardt, Chief Medical Officer, said: “The preclinical derazantinib data may provide an explanation for differences in reported adverse event profiles between various FGFR kinase inhibitors. Furthermore, derazantinib shows promising efficacy in patient-derived tumor models with gene aberrations in FGFR1-3. The data which will be presented at ESMO are part of our broad preclinical and clinical...

Continue reading

Basilea kündigt Präsentation von Daten auf dem ESMO Virtual Congress 2020 an

Basel, 28. Juli 2020Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass drei Abstracts mit präklinischen und klinischen Daten zu ihrem FGFR-Kinase-Inhibitor Derazantinib und ihrem Tumor-Checkpoint-Controller Lisavanbulin als E-Poster auf der Jahrestagung 2020 der Europäischen Gesellschaft für medizinische Onkologie (ESMO) präsentiert werden. Die ESMO Jahrestagung 2020 wird als virtuelle Veranstaltung vom 19. bis 21. September 2020 stattfinden.Dr. Marc Engelhardt, Chief Medical Officer, sagte: „Die präklinischen Derazantinib-Daten könnten eine Erklärung für die Unterschiede der Nebenwirkungsprofile verschiedener FGFR-Kinase-Inhibitoren liefern. Darüber hinaus zeigt Derazantinib eine vielversprechende Aktivität bei Tumormodellen basierend auf Tumorgeweben von Patienten mit Aberrationen der FGFR1-3 Gene. Die bei ESMO gezeigten Daten...

Continue reading

Radient Technologies Inc. Provides Update on Filing of Year-End Financial Statements

EDMONTON, Alberta, July 27, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), announces that the Company will be relying on the temporary 45 day extension to the filing deadline of its annual financial statements and management’s discussion and analysis (“MD&A”) for the year ended March 31, 2020 granted by the Alberta Securities Commission (“ASC”) in response to unprecedented challenges resulting from COVID-19. The notice released states that securities regulators will be providing coordinated relief consisting of a 45-day extension for certain periodic filings required to be made on or prior to August 31, 2020 as a result of the COVID-19 pandemic.As per National Instrument 51-102 Continuous Disclosure Obligations, the Company was to file its annual financial statements...

Continue reading

Lion One Announces Upsize to Previously Announced “Bought Deal” Private Placement of Units to C$35 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESNORTH VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — Lion One Metals Limited (TSX-V: LIO) (OTCQX: LOMLF) (ASX: LLO) (“Lion One” or the “Company“) is pleased to announce that it has amended the terms of its previously announced bought deal private placement financing to increase the size of the offering to C$35 million (the “Upsized Offering”).Under the terms of the Upsized Offering, a syndicate of underwriters co-led by Haywood Securities Inc. and Echelon Wealth Partners Inc. and including Cormark Securities Inc., Eight Capital, and Laurentian Bank Securities Inc. (collectively, the “Underwriters“), have agreed to purchase, on a “bought deal” private placement basis, 20,590,000...

Continue reading

Nabis Holdings Inc. Receives Demand for Payment of Unsecured 8% Debentures Outstanding

VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis” or the “Company”)  announces that they have received a Demand for Payment from Odyssey Trust Company Ltd. The Company was notified after the close of business on July 24, 2020  that Odyssey Trust Company Ltd. has commenced a legal action against the Company, alleging a breach of the Indenture Agreement occurred when Nabis Holdings Inc. deferred the interest payment due to the unsecured debenture holders on June 30, 2020.On July 13, 2020, the Company received notice from the Trustee indicating that the missed June interest payment constitutes an Event of Default as defined in the Indenture and accordingly, the outstanding $35,791,759 representing principal and accrued interest (the “Indebtedness”) of the...

Continue reading

能工网络科技宣布完成首次公开募股融资

中国无锡, July 28, 2020 (GLOBE NEWSWIRE) — 能工网络科技有限公司 (“能工”或“该公司”) (纳斯达克股票代码: EDTK), 一家提供互动在线学习服务的教育技术公司,今天宣布其完成首次公开募股融资,以每股5美元价格发行3,000,000股普通股。该公司股票以“EDTK”为交易代码已于美国东部时间2020年7月23日在纳斯达克公开交易。The Benchmark Company担任本次公开募股的主要账簿管理人, Axiom Capital Management担任联席账簿管理人。有关发行的最终招股说明书的电子副本可以在美国证券交易委员会网站(www.sec.gov)上获得,也可以通过The Benchmark Company获得,邮件收件人: Prospectus Department, 150 E. 58th Street, 17th floor, New York, NY 10155,电邮 prospectus@benchmarkcompany.com 或致电+1(212) 312-6700。有关本次首次公开募股的F-1申请登记表已于2020年6月30日提交美国证券交易委员会(“SEC”),并已由美国证券交易委员会宣布生效。本新闻稿并不构成销售邀约或购买邀请;如果有任何州或司法管辖区的证券法规定在登记或取得资格之前做此类邀约或出售均为非法行为,则不得在这些州或司法管辖区出售此类证券。关于能工网络科技有限公司能工网络科技有限公司是一家提供交互式在线职业培训和虚拟模拟实验培训课程的教育科技公司。 该公司于2013年在中国无锡成立,是中国经济发展和劳动就业教育改革的主要支持者。 公司目前拥有5950万名注册会员和310万名付费会员。欲了解更多信息,请访问公司网站:http://ir.kingwayup.com/。详情请垂询:能工网络科技有限公司Frank Wang,投资者关系总监邮箱: Frankwang@kingwayedu.cn埃森德投资者关系公司Tina...

Continue reading

First Savings Financial Group, Inc. Reports Financial Results for the Third Fiscal Quarter Ended June 30, 2020

JEFFERSONVILLE, Ind., July 27, 2020 (GLOBE NEWSWIRE) — First Savings Financial Group, Inc. (NASDAQ: FSFG – news) (the “Company”), the holding company for First Savings Bank (the “Bank”), today reported net income of $15.4 million, or $6.51 per diluted share, for the quarter ended June 30, 2020 compared to net income of $4.4 million, or $1.85 per diluted share, for the quarter ended June 30, 2019.Commenting on the Company’s performance, Larry W. Myers, President and CEO stated: “We are very pleased with the outstanding quarter, including the stellar level of reported earnings, $2.9 million increase in allowance for loan losses, resiliency of asset quality, stability of the net interest margin, significant increase in stockholders’ equity, and substantial increase in shareholder value. The core bank,...

Continue reading

Allena Pharmaceuticals Increases Previously Announced Bought Deal to $6.7 Million

NEWTON, Mass., July 27, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 5,125,384 shares of common stock of the Company, at a price to the public of $1.30 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 30, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted...

Continue reading

Titanium Corporation Inc. Announces Appointment of Bruce Griffin as New Chair of Commercialization Committee

CALGARY, Alberta, July 27, 2020 (GLOBE NEWSWIRE) — Titanium Corporation Inc. (the “Company” or “Titanium”) (TSX-V: TIC) is pleased to announce that, effective July 27, 2020, Mr. Bruce Griffin will assume the role of Chair of the Commercialization Committee of the Board of Directors (the “Committee“) of the Company. Mr. Griffin, who is currently a member of the Committee, will be replacing Mr. David Macdonald, who has been the Chair of the Committee since 2017. Mr. Macdonald will remain a member of the Committee. A copy of the charter of the Committee is available on the Company’s website at http://www.titaniumcorporation.com/corporate/corporate-governance/.“Titanium is delighted that Bruce has agreed to assume this important position,” stated David Macdonald, Titanium’s...

Continue reading

Candelaria Announces Grant of Stock Options

VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — Candelaria Mining Corp. (TSXV:CAND, OTC PINK:CDELF) (the “Company”) announces the grant of incentive stock options pursuant to its stock option plan, to directors and officers of the Company, to purchase up to an aggregate of 2,250,000 common shares of the Company at a price of $0.30 per share expiring five years from the date of grant.  In addition, the Company has granted directors and officers of the Company 2,060,000 restricted share units at a price of $0.30 per share.  All options and restricted share units vest in three equal installments over 18 months. About Candelaria MiningCandelaria Mining is a Canadian-based gold development and exploration company with a portfolio of highly prospective projects in Mexico, one of the world’s best mining jurisdictions. Candelaria’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.